Renaissance Capital logo

RKDA News

A new GMO IPO: Bioceres files for an $81 million US IPO

BIOX

Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, filed on Thursday with the SEC to raise up to $81 million in an initial public offering. Bioceres has partnered with Arcadia Biosciences (RKDA), Dow (NYSE: DOW) and Verdeca to develop a soybean that demonstrates high tolerance to drought and salinity. The Rosario,...read more

US IPO Weekly Recap: With 6 IPOs, the year's largest company goes public

Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its range to become the year's largest company to go public by market cap. We also saw the ...read more

Arcadia Biosciences prices IPO at $8 after cutting proposed valuation

Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, raised $66 million by offering 8.2 million shares at $8. Before cutting its terms on Thursday, the company had planned to offer 7.2 million shares at $13-$15. Arcadia Biosciences plans to list on the NASDAQ under the symbol RKDA. Arcadia Biosciences initially filed...read more

Cut the crop: Arcadia Biosciences slashes proposed IPO size by 34%

Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, lowered the proposed deal size for its upcoming IPO on Thursday. The Davis, CA-based company now plans to raise $66 million by offering 8.2 million shares at a price of $8. The company had previously filed to offer 7.2 million shares at a range of $13 to $15. At the...read more